Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01390766

Enrollment

Registered

2011-07-11

Start date

2002-08-31

Completion date

2011-05-31

Last updated

2012-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases

Keywords

Antirejection

Brief summary

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Interventions

DRUGAzathioprine

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Subjects who undergo liver transplantation and azathioprine tablet was administered

Exclusion criteria

As this is PMS study, there are no

Design outcomes

Primary

Measure	Time frame
The number of incidence of adverse events related to azathioprine tablets and serious adverse events	1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026